南卡羅來納州 的 肺癌 臨床試驗
19 項針對 肺癌 的研究正在 南卡羅來納州 各地點尋找參與者。
南卡羅來納州 的城市
- Charleston11 項研究
- Greenville9 項研究
- Spartanburg7 項研究
- Greer7 項研究
- Anderson5 項研究
- Florence4 項研究
- Columbia4 項研究
- Easley3 項研究
官方研究文本（英文）
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
- Ralph H Johnson VA Medical Center, Charleston
- Medical University of South Carolina, Charleston
招募中3 期
70 歲及以上 · 所有性別 · 更新於 2026年10月5日 · NCT06096844Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Saint Joseph's/Candler - Bluffton Campus, Bluffton
- Prisma Health Cancer Institute - Spartanburg, Boiling Springs
- Bon Secours Saint Francis Hospital, Charleston
- 還有 15 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月5日 · NCT04267848Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- AnMed Health Cancer Center, Anderson
- Prisma Health Richland Hospital, Columbia
- McLeod Regional Medical Center, Florence
- 還有 12 項
招募中觀察性研究歡迎健康志工
40 至 75 歲 · 所有性別 · 更新於 2026年10月2日 · NCT05334069Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Prisma Health Cancer Institute - Spartanburg, Boiling Springs
- Prisma Health Cancer Institute - Easley, Easley
- Gibbs Cancer Center-Gaffney, Gaffney
- 還有 9 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT06498635A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
- Saint Joseph's Candler Health System ( Site 4010), Bluffton
- Medical University of South Carolina-Hollings Cancer Center ( Site 0045), Charleston
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06312137A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Medical University of South Carolina, Florence
- Medical University of South Carolina Health Lancaster Medical Center, Lancaster
招募中3 期
18 至 100 歲 · 所有性別 · 更新於 2026年9月25日 · NCT05920356A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
- Local Institution - 0608, Greenville
招募中2/3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月23日 · NCT07063745A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Medical University of South Carolina, Charleston
- Prisma Health Cancer Institute, Greenville
- Lexington Medical Center, West Columbia
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月8日 · NCT06119581Health Education Approach to Lung Screening
- Medical University of South Carolina, Charleston
招募中歡迎健康志工
50 至 80 歲 · 所有性別 · 更新於 2026年8月25日 · NCT06070870Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- Saint Joseph's/Candler - Bluffton Campus, Bluffton
- Gibbs Cancer Center-Gaffney, Gaffney
- Saint Francis Hospital, Greenville
- 還有 8 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年8月17日 · NCT05624996Prediction Augmented Screening Initiative
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
招募中
50 至 80 歲 · 所有性別 · 更新於 2026年6月26日 · NCT06538636Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- AnMed Health Cancer Center, Anderson
- Saint Joseph's/Candler - Bluffton Campus, Bluffton
- Prisma Health Cancer Institute - Spartanburg, Boiling Springs
- 還有 9 項
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年6月3日 · NCT05642572Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- AnMed Health Cancer Center, Anderson
- Saint Joseph's/Candler - Bluffton Campus, Bluffton
- Medical University of South Carolina, Charleston
- 還有 5 項
招募中2/3 期
18 歲及以上 · 所有性別 · 更新於 2026年5月5日 · NCT06616584Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- AnMed Health Cancer Center, Anderson
招募中2 期
18 Minutes · 所有性別 · 更新於 2026年5月5日 · NCT06031688cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Medical University of South Carolina, Charleston
- McLeod Health, Florence
招募中觀察性研究歡迎健康志工
40 歲及以上 · 所有性別 · 更新於 2026年1月20日 · NCT05366881LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
- AnMed Health Cancer Center, Anderson
- Saint Joseph's/Candler - Bluffton Campus, Bluffton
- Gibbs Cancer Center-Gaffney, Gaffney
- 還有 7 項
招募中觀察性研究
18 歲及以上 · 所有性別 · 更新於 2026年1月9日 · NCT06073431SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Greenville
招募中觀察性研究
所有年齡 · 所有性別 · 更新於 2025年10月28日 · NCT03452774Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Medical University of South Carolina (MUSC), Charleston
- McLeod Health, Florence
招募中觀察性研究
50 歲及以上 · 所有性別 · 更新於 2025年8月5日 · NCT06122077Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
- Ralph H. Johnson VA Health Care System, Charleston
招募中觀察性研究
29 至 85 歲 · 所有性別 · 更新於 2024年11月13日 · NCT06426628資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。